OBIO — Orchestra Biomed Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- $192.15m
- $126.97m
- $2.76m
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | 8-K | 8-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 35.8 | 10.9 | 83.8 | 87.6 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.168 | 0.121 | 0.096 | 0.099 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Current Assets | 36.3 | 11.3 | 84.7 | 89.1 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 1.03 | 1.12 | 3.68 | 2.83 |
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 38.1 | 13.5 | 95.6 | 95.2 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 14.4 | 12.2 | 18.6 | 11.2 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 35.2 | 33.3 | 43 | 27.2 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Unrealized Gain / Loss | ||||
Total Equity | 2.91 | -19.8 | 52.5 | 68 |
Total Liabilities & Shareholders' Equity | 38.1 | 13.5 | 95.6 | 95.2 |
Total Common Shares Outstanding |